VentriPoint Diagnostics Ltd. (VPT.V)
CAD 0.1
(11.11%)
CAD 0.1
(11.11%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -4.87 Million CAD | 0.02% |
| 2022 | -4.87 Million CAD | -25.55% |
| 2021 | -3.88 Million CAD | -109.71% |
| 2020 | -1.85 Million CAD | 44.3% |
| 2019 | -3.32 Million CAD | -59.43% |
| 2018 | -2.08 Million CAD | 43.72% |
| 2017 | -3.7 Million CAD | -41.14% |
| 2016 | -2.62 Million CAD | -73.26% |
| 2015 | -1.51 Million CAD | 30.77% |
| 2014 | -2.18 Million CAD | -32.62% |
| 2013 | -1.64 Million CAD | 59.01% |
| 2012 | -4.02 Million CAD | -19.84% |
| 2011 | -3.35 Million CAD | -32.09% |
| 2010 | -2.54 Million CAD | -37.98% |
| 2009 | -1.84 Million CAD | 64.67% |
| 2008 | -5.21 Million CAD | -276.95% |
| 2007 | -1.38 Million CAD | -5171.85% |
| 2006 | -26.23 Thousand CAD | 74.68% |
| 2005 | -103.63 Thousand CAD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -1.18 Million CAD | 3.85% |
| 2024 Q2 | -1.41 Million CAD | -19.34% |
| 2023 Q1 | -1.34 Million CAD | -21.82% |
| 2023 FY | -4.87 Million CAD | 0.02% |
| 2023 Q3 | -1.17 Million CAD | -5.3% |
| 2023 Q4 | -1.23 Million CAD | -5.35% |
| 2023 Q2 | -1.11 Million CAD | 17.11% |
| 2022 Q1 | -1 Million CAD | 7.97% |
| 2022 Q3 | -1.4 Million CAD | -3.7% |
| 2022 Q4 | -1.1 Million CAD | 21.38% |
| 2022 FY | -4.87 Million CAD | -25.55% |
| 2022 Q2 | -1.35 Million CAD | -34.22% |
| 2021 Q2 | -529.17 Thousand CAD | 63.28% |
| 2021 Q4 | -1.09 Million CAD | -50.04% |
| 2021 Q3 | -730.83 Thousand CAD | -38.11% |
| 2021 Q1 | -1.44 Million CAD | -1002.68% |
| 2021 FY | -3.88 Million CAD | -109.71% |
| 2020 Q3 | -608.13 Thousand CAD | -98.37% |
| 2020 Q1 | -805.28 Thousand CAD | -30.02% |
| 2020 FY | -1.85 Million CAD | 44.3% |
| 2020 Q4 | -130.7 Thousand CAD | 78.51% |
| 2020 Q2 | -306.55 Thousand CAD | 61.93% |
| 2019 Q3 | -543.03 Thousand CAD | 36.96% |
| 2019 Q4 | -619.33 Thousand CAD | -14.05% |
| 2019 Q1 | -1.29 Million CAD | -31.54% |
| 2019 FY | -3.32 Million CAD | -59.43% |
| 2019 Q2 | -861.37 Thousand CAD | 33.68% |
| 2018 Q2 | -930.72 Thousand CAD | -1749.5% |
| 2018 FY | -2.08 Million CAD | 43.72% |
| 2018 Q3 | -115.5 Thousand CAD | 87.59% |
| 2018 Q4 | -987.46 Thousand CAD | -754.93% |
| 2018 Q1 | -50.32 Thousand CAD | 97.44% |
| 2017 Q3 | 199.51 Thousand CAD | -89.21% |
| 2017 Q2 | 1.84 Million CAD | 148.81% |
| 2017 Q1 | -3.78 Million CAD | -544.53% |
| 2017 FY | -3.7 Million CAD | -41.14% |
| 2017 Q4 | -1.96 Million CAD | -1083.75% |
| 2016 FY | -2.62 Million CAD | -73.26% |
| 2016 Q2 | -748.9 Thousand CAD | -8.0% |
| 2016 Q1 | -693.44 Thousand CAD | -526.93% |
| 2016 Q4 | -587.98 Thousand CAD | -1.14% |
| 2016 Q3 | -581.37 Thousand CAD | 22.37% |
| 2015 FY | -1.51 Million CAD | 30.77% |
| 2015 Q2 | -675.02 Thousand CAD | -123.38% |
| 2015 Q4 | -110.6 Thousand CAD | 68.73% |
| 2015 Q3 | -353.71 Thousand CAD | 47.6% |
| 2015 Q1 | -302.19 Thousand CAD | -24.49% |
| 2014 FY | -2.18 Million CAD | -32.62% |
| 2014 Q3 | -576.09 Thousand CAD | 33.8% |
| 2014 Q1 | -446.9 Thousand CAD | -142.76% |
| 2014 Q2 | -870.28 Thousand CAD | -94.73% |
| 2014 Q4 | -242.75 Thousand CAD | 57.86% |
| 2013 Q4 | 1.04 Million CAD | 165.86% |
| 2013 FY | -1.64 Million CAD | 59.01% |
| 2013 Q2 | -731.95 Thousand CAD | -90.38% |
| 2013 Q1 | -384.46 Thousand CAD | 57.11% |
| 2013 Q3 | -1.58 Million CAD | -116.82% |
| 2012 Q2 | -1.38 Million CAD | -75.7% |
| 2012 Q4 | -896.47 Thousand CAD | 10.9% |
| 2012 FY | -4.02 Million CAD | -19.84% |
| 2012 Q1 | -789.54 Thousand CAD | -138.22% |
| 2012 Q3 | -1 Million CAD | 27.48% |
| 2011 Q3 | -1.27 Million CAD | -26.39% |
| 2011 Q1 | -627.95 Thousand CAD | 14.36% |
| 2011 Q2 | -1 Million CAD | -60.7% |
| 2011 FY | -3.35 Million CAD | -32.09% |
| 2011 Q4 | -331.42 Thousand CAD | 74.01% |
| 2010 Q3 | -867.23 Thousand CAD | -30.38% |
| 2010 Q1 | -286.9 Thousand CAD | 34.45% |
| 2010 Q4 | -733.26 Thousand CAD | 15.45% |
| 2010 FY | -2.54 Million CAD | -37.98% |
| 2010 Q2 | -665.17 Thousand CAD | -131.85% |
| 2009 FY | -1.84 Million CAD | 64.67% |
| 2009 Q4 | -437.67 Thousand CAD | -34.77% |
| 2009 Q1 | -723.63 Thousand CAD | 61.59% |
| 2009 Q2 | -507.5 Thousand CAD | 29.87% |
| 2009 Q3 | -324.74 Thousand CAD | 36.01% |
| 2008 Q3 | -1.26 Million CAD | -16.58% |
| 2008 Q2 | -1.08 Million CAD | -17.63% |
| 2008 Q1 | -919.09 Thousand CAD | -19.51% |
| 2008 FY | -5.21 Million CAD | -276.95% |
| 2008 Q4 | -1.88 Million CAD | -49.49% |
| 2007 Q3 | -204.34 Thousand CAD | -19875.19% |
| 2007 Q1 | -45.75 Thousand CAD | -178.22% |
| 2007 FY | -1.38 Million CAD | -5171.85% |
| 2007 Q4 | -769.06 Thousand CAD | -276.36% |
| 2007 Q2 | -1022.98 CAD | 97.76% |
| 2006 Q1 | -10 Thousand CAD | 0.0% |
| 2006 Q3 | 1794.38 CAD | 214.06% |
| 2006 Q2 | -1573.25 CAD | 84.28% |
| 2006 Q4 | -16.44 Thousand CAD | -1016.48% |
| 2006 FY | -26.23 Thousand CAD | 74.68% |
| 2005 FY | -103.63 Thousand CAD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Perimeter Medical Imaging AI, Inc. | -18.94 Million CAD | 74.283% |
| Therma Bright Inc. | -3.76 Million CAD | -29.306% |
| Theralase Technologies Inc. | -4.57 Million CAD | -6.586% |